FREE Account Opening + No Clearing Fees
Loading...

Infollion Research Services IPO vs Remus Pharmaceuticals IPO

Comparision between Infollion Research Services IPO and Remus Pharmaceuticals IPO.

IPO Details

Infollion Research Services IPO is a SME Book Built Issue IPO proposed to list at NSE SME while Remus Pharmaceuticals IPO is a SME Book Built Issue proposed to list at NSE SME.

  Infollion Research Services IPO Remus Pharmaceuticals IPO
Logo Infollion Research Services IPO Logo Remus Pharmaceuticals IPO Logo
Issue Category SME SME
Issue Type IPO IPO
Process Type Book Built Issue Book Built Issue
Listing At NSE SME NSE SME
Lead Managers Holani Consultants Private Limited Beeline Capital Advisors Pvt Ltd
Registrar Link Intime India Private Ltd Link Intime India Private Ltd
Market Maker Holani Consultants Private Limited Sunflower Broking Private Limited
DRHP DRHP DRHP
RHP RHP RHP
Anchor Investor Anchor Investor Anchor Investor
IPO Allotment URL IPO Allotment URL IPO Allotment URL

Issue Size and Price

The total issue size of Infollion Research Services IPO is up to ₹21.45 Cr whereas the issue size of the Remus Pharmaceuticals IPO is up to ₹47.69 Cr. The final issue price of Infollion Research Services IPO is ₹82.00 per share and of Remus Pharmaceuticals IPO is ₹1,229.00 per share.

  Infollion Research Services IPO Remus Pharmaceuticals IPO
Face Value ₹10 per share ₹10 per share
Issue Price (Lower) ₹80.00 per share ₹1,150.00 per share
Issue Price (Upper) ₹82.00 per share ₹1,229.00 per share
Issue Price (Final) ₹82.00 per share ₹1,229.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 1600 shares 100 shares
Fresh Issue Size 22,24,000 shares 3,88,000 shares
Fresh Issue Size (Amount) up to ₹18.24 Cr up to ₹47.69 Cr
OFS Issue Size 3,92,000 shares
OFS Issue Size (Amount) up to ₹3.21 Cr
Issue Size Total 26,16,000 shares 3,88,000 shares
Issue Size Total (Amount) up to ₹21.45 Cr up to ₹47.69 Cr

IPO Timetable

Infollion Research Services IPO opens on May 29, 2023, while Remus Pharmaceuticals IPO opens on May 17, 2023. The closing date of Infollion Research Services IPO and Remus Pharmaceuticals IPO is May 31, 2023, and May 19, 2023, respectively.

  Infollion Research Services IPO Remus Pharmaceuticals IPO
Anchor Bid Date May 26, 2023 May 16, 2023
Issue Open May 29, 2023 May 17, 2023
Issue Close May 31, 2023 May 19, 2023
Basis Of Allotment (Tentative) Jun 05, 2023 May 24, 2023
Initiation of Refunds (Tentative) Jun 06, 2023 May 25, 2023
Credit of Share (Tentative) Jun 07, 2023 May 26, 2023
Listing date (Tentative) Jun 08, 2023 May 29, 2023
Anchor Lockin End date 1 Jul 05, 2023 Jun 23, 2023
Anchor Lockin End date 2 Sep 03, 2023 Aug 22, 2023

Financials

Infollion Research Services IPO P/E ratio is 14.24, as compared to Remus Pharmaceuticals IPO P/E ratio of 21.09.

  Infollion Research Services IPO Remus Pharmaceuticals IPO
Financial
Infollion Research Services Limited Financial Information (Restated)
Period EndedTotal AssetsTotal RevenueProfit After TaxNet WorthReserves and SurplusTotal Borrowing
31-Mar-21848.741,606.46207.65702.47700.980.00
31-Mar-221,181.322,220.13340.661,043.121,041.640.00
31-Mar-231,800.553,529.92557.921,601.05854.360.00
Amount in ₹ Lakhs
Remus Pharmaceuticals Limited Financial Information (Restated)
Period EndedTotal AssetsTotal RevenueProfit After TaxNet WorthReserves and SurplusTotal Borrowing
31-Mar-20530.361,276.8981.16202.03201.0335.93
31-Mar-211,104.961,922.45102.58304.61303.6127.89
31-Mar-221,590.932,543.71338.57643.17543.1719.17
31-Dec-223,352.963,361.20643.901,712.071,603.57947.45
Amount in ₹ Lakhs
Promoter Shareholding (Pre-Issue) 67.09% 92.82%
Promoter Shareholding (Post-Issue) 68.37%
P/E Ratio 14.24 21.09
Market Cap ₹79.47 Cr. ₹181.03 Cr.
ROE 42.20%% 71.44%%
ROCE 69.99%%
Debt/Equity 0.03
EPS ₹33.86
RoNW 52.64%%

Shares Offered

In the Infollion Research Services IPO retail investors (RII) are offered 8,70,400 shares while in Remus Pharmaceuticals IPO retail investors are offered 8,70,400 shares. Qualified institutional buyers (QIB) are offered 4,83,200 shares in Infollion Research Services IPO and 1,38,750 shares in Remus Pharmaceuticals IPO.

  Infollion Research Services IPO Remus Pharmaceuticals IPO
Anchor Investor Reserveration 7,24,800 shares 1,10,500 shares
Market Maker Reserveration 1,32,800 shares 19,500 shares
QIB 4,83,200 shares 1,38,750 shares
NII 4,04,800 shares 41,625 shares
RII 8,70,400 shares 97,125 shares
Employee 0 shares 0 shares
Others
Total 17,58,400 shares 2,77,500 shares

Bids Received (Subscription)

Infollion Research Services IPO subscribed 279.24x in total, whereas Remus Pharmaceuticals IPO subscribed 57.21x.

  Infollion Research Services IPO Remus Pharmaceuticals IPO
QIB (times) 70.72x 10.75x
NII (times) 560.71x 229.31x
Big NII (times)
Small NII (times)
RII (times) 264.10x 49.81x
Employee (times)
Other (times)
Total (times) 279.24x 57.21x

Comments

Add a public comment...